Peter Roy-Byrne mainly focuses on Psychiatry, Anxiety, Anxiety disorder, Clinical psychology and Panic disorder. His work in Depression, Comorbidity, Mood, Mental health and Psychopathology are all subfields of Psychiatry research. The Anxiety study combines topics in areas such as Irritable bowel syndrome and Pharmacotherapy.
His work deals with themes such as GABA reuptake inhibitor, Tiagabine, Placebo, Chronic pain and Placebo-controlled study, which intersect with Anxiety disorder. His Clinical psychology research is multidisciplinary, relying on both Ethnic group, Social environment, Cultural diversity and Rating scale. The concepts of his Panic disorder study are interwoven with issues in Healthy control, Panic and Collaborative Care.
His primary areas of investigation include Psychiatry, Depression, Clinical psychology, Anxiety and Panic disorder. Psychiatry is often connected to Psychotherapist in his work. As a part of the same scientific study, Peter Roy-Byrne usually deals with the Depression, concentrating on Internal medicine and frequently concerns with Endocrinology.
In most of his Clinical psychology studies, his work intersects topics such as Substance abuse. His Anxiety study integrates concerns from other disciplines, such as Randomized controlled trial and Collaborative Care. His research is interdisciplinary, bridging the disciplines of Panic and Panic disorder.
The scientist’s investigation covers issues in Psychiatry, Depression, Clinical psychology, Anxiety and Psychotherapist. In his research, Peter Roy-Byrne undertakes multidisciplinary study on Psychiatry and Suicidal ideation. His studies deal with areas such as Anesthesia, Transcranial magnetic stimulation and Internal medicine as well as Depression.
His Clinical psychology study combines topics in areas such as Mental health and Panic disorder. The various areas that Peter Roy-Byrne examines in his Anxiety study include Randomized controlled trial and Mood. His research combines Substance abuse and Comorbidity.
Peter Roy-Byrne focuses on Psychiatry, Anxiety, Depression, Clinical psychology and Psychotherapist. His Psychiatry research incorporates themes from Older patients and Coronavirus disease 2019. His biological study spans a wide range of topics, including Addiction, Collaborative Care, Medical education and Mood.
Peter Roy-Byrne interconnects Traumatic stress and Internal medicine, Prolonged exposure in the investigation of issues within Depression. Peter Roy-Byrne has included themes like Cognition, Anxiety sensitivity, Moderation, Panic disorder and Mental health in his Clinical psychology study. His research on Comorbidity also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients.
Joan Russo;Carol A. Trujillo;Dane Wingerson;Kathleen Decker.
Medical Care (1998)
Anxiety disorders and comorbid medical illness
Peter P. Roy-Byrne;Karina W. Davidson;Ronald C. Kessler;Gordon J.G. Asmundson.
General Hospital Psychiatry (2008)
Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.
Peter Roy-Byrne;Michelle G. Craske;Greer Sullivan;Raphael D. Rose.
JAMA (2010)
Implementation of the CALM intervention for anxiety disorders: a qualitative study.
Geoffrey M Curran;Greer Sullivan;Peter Mendel;Michelle G Craske.
Implementation Science (2012)
Psychedelic Effects of Ketamine in Healthy Volunteers Relationship to Steady-state Plasma Concentrations
Andrew T. Bowdle;Allen D. Radant;Deborah S. Cowley;Evan D. Kharasch.
Anesthesiology (1998)
Premenstrual syndromes: Overview from a methodologic perspective
Rubinow Dr;Roy-Byrne P.
American Journal of Psychiatry (1984)
A Randomized Effectiveness Trial of Cognitive-Behavioral Therapy and Medication for Primary Care Panic Disorder
Peter P. Roy-Byrne;Michelle G. Craske;Murray B. Stein;Greer Sullivan.
Archives of General Psychiatry (2005)
A Controlled Study of Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Major Depression
David H. Avery;Paul E. Holtzheimer;Paul E. Holtzheimer;Walid Fawaz;Walid Fawaz;Joan Russo.
Biological Psychiatry (2006)
Antidepressant effects of carbamazepine.
R M Post;T W Uhde;P P Roy-Byrne;R T Joffe.
American Journal of Psychiatry (1986)
A Randomized Effectiveness Trial of Stepped Collaborative Care for Acutely Injured Trauma Survivors
Douglas Zatzick;Peter Roy-Byrne;Joan Russo;Frederick Rivara.
Archives of General Psychiatry (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, Los Angeles
University of Washington
RAND Corporation
University of California, San Diego
University of Washington
George Washington University
University of California, Los Angeles
University of North Carolina at Chapel Hill
RAND Corporation
University of California, San Diego
Ghent University
University of Wisconsin–Madison
Ruhr University Bochum
Ford Motor Company (United States)
Max Planck Institute for Intelligent Systems
Eindhoven University of Technology
Washington State University
Aix-Marseille University
Université Laval
Swedish University of Agricultural Sciences
United States Department of Veterans Affairs
California Institute of Technology
Indiana University – Purdue University Indianapolis
University of Milan
Washington University in St. Louis
London School of Economics and Political Science